You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

MANNITOL 15% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Mannitol 15% In Plastic Container patents expire, and what generic alternatives are available?

Mannitol 15% In Plastic Container is a drug marketed by B Braun and Icu Medical Inc and is included in two NDAs.

The generic ingredient in MANNITOL 15% IN PLASTIC CONTAINER is mannitol. There are eighteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the mannitol profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for MANNITOL 15% IN PLASTIC CONTAINER?
  • What are the global sales for MANNITOL 15% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for MANNITOL 15% IN PLASTIC CONTAINER?
Summary for MANNITOL 15% IN PLASTIC CONTAINER
Drug patent expirations by year for MANNITOL 15% IN PLASTIC CONTAINER
Recent Clinical Trials for MANNITOL 15% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, GenevaPhase 3
Morten Hostrup, PhDN/A
Ecole Polytechnique Fédérale de LausanneEarly Phase 1

See all MANNITOL 15% IN PLASTIC CONTAINER clinical trials

Pharmacology for MANNITOL 15% IN PLASTIC CONTAINER
Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

US Patents and Regulatory Information for MANNITOL 15% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun MANNITOL 15% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 020006-003 Jul 26, 1993 AP RX No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Icu Medical Inc MANNITOL 15% IN PLASTIC CONTAINER mannitol INJECTABLE;INJECTION 019603-003 Jan 8, 1990 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

EU/EMA Drug Approvals for MANNITOL 15% IN PLASTIC CONTAINER

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Pharmaxis Europe Limited Bronchitol mannitol EMEA/H/C/001252
Bronchitol is indicated for the treatment of cystic fibrosis (CF) in adults aged 18 years and above as an add-on therapy to best standard of care.
Authorised no no no 2012-04-13
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

MANNITOL 15% IN PLASTIC CONTAINER Market Analysis and Financial Projection Experimental

Mannitol Market Dynamics and Financial Trajectory

Introduction to Mannitol

Mannitol, a sugar alcohol, is widely used in various industries, including pharmaceuticals, food, and beverages. Its applications range from being an excipient in pharmaceutical formulations to a sweetener in low-calorie foods. Here, we will delve into the market dynamics and financial trajectory of mannitol, particularly focusing on its use in medical applications such as Mannitol 15% in plastic containers.

Market Size and Growth

The global mannitol market has been experiencing significant growth over the past few years. In 2022, the market size was estimated to be around USD 418.65 million[1][2][3].

  • Projected Growth: The market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.1% from 2023 to 2033, reaching a projected value of USD 890.31 million by 2033[1].
  • Alternative Projections: Other reports suggest a CAGR of 6.8% from 2024 to 2031, with the market expected to reach USD 754.70 million by 2031[2], and a CAGR of 4.9% from 2023 to 2030, reaching USD 584.47 million by 2030[3].

Key Drivers of Growth

Several factors are driving the growth of the mannitol market:

Increasing Population and Lifestyle Changes

The global population is growing, and lifestyle changes are leading to an increase in certain diseases, which in turn increases the demand for mannitol in pharmaceutical and food applications[1][2].

Rising Health Consciousness

Consumers are becoming more health-conscious, leading to an increased demand for low-calorie and non-cariogenic sweeteners like mannitol. This trend is particularly strong in the food and beverage sector[1][5].

Pharmaceutical Applications

Mannitol is used as an excipient in pharmaceutical products and for treating various medical conditions such as brain, kidney, and heart problems. Its use in reducing intracranial pressure and treating cerebral edema is also significant[1][2][3].

Technological Advancements

Recent technological advancements, such as the synthesis of mannitol using lactic acid bacteria, are expected to boost production efficiency and purity, further supporting market growth[2].

Regional Market Dynamics

Asia Pacific

  • China: China is the largest consumer of bulk mannitol in the Asia-Pacific region and accounts for over 52.9% of the region's market share. The country's growing food and beverage industry and increasing demand for sugar alternatives are key drivers[1].
  • India: India dominates the South Asia market with a significant market share. The rising prevalence of diabetes, obesity, and heart disorders in India is driving the demand for alternative sweeteners like mannitol[1].

North America

  • This region is expected to hold a significant market share due to the high prevalence of acute renal failure and traumatic brain injuries. The well-developed healthcare infrastructure and positive reimbursement policies are also driving the market[3][4].

Europe

  • Europe is expected to represent a substantial revenue share, driven by the increasing use of mannitol infusions for treating conditions like cystic fibrosis and cerebral edema[3].

Application-Specific Growth

Pharmaceuticals

  • Mannitol is widely used in hospital pharmacies, retail pharmacies, and online pharmacies. The 20g/100 ml concentration is expected to be the largest revenue segment due to its use in treating conditions like increased intracranial pressure and renal failure[3].

Food and Beverages

  • The demand for mannitol in the food and beverage sector is increasing due to its use as a low-calorie sweetener and its cooling effect in products like mint-based sweets and gums[1][5].

Financial Trajectory

  • Volume Sales: The volume sales of mannitol are expected to rise at a rate of 5.62% in 2023, with shipments reaching 66,998 MT in the same year[1].
  • Revenue Forecast: By 2033, the market is projected to reach USD 890.31 million, with a CAGR of 7.1% from 2023 to 2033[1].
  • Regional Revenue: North America is currently leading the mannitol injection market, driven by advanced healthcare infrastructure and significant healthcare spending. The Asia-Pacific region is also expected to experience rapid growth due to increasing healthcare spending and urbanization[4].

Challenges and Opportunities

Challenges

  • The COVID-19 pandemic had a significant impact on the mannitol market, leading to production shutdowns and economic downturns in several countries. Economic conditions in severely affected countries remain a critical factor that could hinder market growth[3].
  • The ongoing recession and geopolitical conflicts, such as the Ukraine-Russia war, also pose challenges to the market[3].

Opportunities

  • The growing demand for low-calorie sweeteners and the increasing health consciousness among consumers present significant opportunities for the mannitol market.
  • Technological advancements in production processes and the expanding use of mannitol in various applications are also expected to drive market growth[1][2][5].

Key Players and Competitive Landscape

The mannitol market is competitive, with several key players involved in the production and distribution of mannitol. These companies are launching new products and investing in research and development to enhance their market share. The competitive landscape is characterized by a mix of global and regional players, with China and India being significant hubs for production and consumption[1][2][3].

Conclusion

The mannitol market, particularly for medical applications like Mannitol 15% in plastic containers, is poised for significant growth driven by increasing health consciousness, technological advancements, and expanding applications in pharmaceuticals and food. Despite challenges such as economic downturns and geopolitical conflicts, the market's positive outlook is supported by strong demand and ongoing innovations.

Key Takeaways

  • The global mannitol market is expected to grow at a CAGR of 7.1% from 2023 to 2033.
  • Increasing health consciousness and the demand for low-calorie sweeteners are key drivers.
  • Asia-Pacific, particularly China and India, are significant markets due to growing health awareness and urbanization.
  • Technological advancements in production are expected to boost market growth.
  • The pharmaceutical sector, especially hospital pharmacies, is a major application area.

Frequently Asked Questions (FAQs)

Q: What is the projected market size of the global mannitol market by 2033? A: The global mannitol market is projected to reach USD 890.31 million by 2033[1].

Q: What are the primary drivers of the mannitol market growth? A: The primary drivers include increasing population, lifestyle changes, rising health consciousness, and technological advancements in production[1][2][5].

Q: Which region is expected to dominate the mannitol market? A: Asia-Pacific, particularly China, is expected to dominate the mannitol market due to its large consumer base and growing food and beverage industry[1].

Q: How does mannitol benefit the pharmaceutical industry? A: Mannitol is used as an excipient in pharmaceutical products and for treating various medical conditions such as brain, kidney, and heart problems[1][2][3].

Q: What impact did the COVID-19 pandemic have on the mannitol market? A: The COVID-19 pandemic led to production shutdowns and economic downturns, impacting the mannitol market. However, the market is recovering as lockdowns are eased and economic activities resume[3].

Cited Sources

  1. Future Market Insights: Mannitol Market Size, Share, Outlook & Forecast by 2033.
  2. SkyQuest: Mannitol Market Growth, Size & Share Analysis | 2031.
  3. SNS Insider: Mannitol Market Size & Share Report Forecast 2023-2030.
  4. Verified Market Research: In-Depth Industry Outlook: Mannitol Injection Market Size & Forecast.
  5. Knowledge Sourcing: Mannitol Market Size & Share: Industry Report, 2024 - 2029.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.